OncoSenX Company
OncoSenX is a developer of transient gene therapies designed for solid tumors.
Investors Number:
8
Last Funding Date:
2021
Total Funding:
11700000
Founded Date:
2017
Headquarters:
Seattle, Washington, United States
Employee Number:
1-10
Estimated Revenue:
$10M to $50M
Last Funding Type:
Seed
Investor Type:
Seed
Industry:
Biotechnology, Health Care